🇺🇸 FDA
Patent

US 6166008

Treatment of schizophrenia with ampakines and neuroleptics

expired A61KA61K45/06A61P

Quick answer

US patent 6166008 (Treatment of schizophrenia with ampakines and neuroleptics) held by The Regents of the University of California expires Mon Dec 21 2020 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Dec 26 2000 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 21 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
26
CPC classes
A61K, A61K45/06, A61P, A61P25/18